NuCana plc is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative cancer treatments. Utilizing its proprietary ProTides platform, the company aims to improve upon existing therapies by delivering enhanced efficacy and reduced side effects. Through its dedication to innovation and strategic collaborations, NuCana is poised to make a significant impact in the field of oncology.
